MW ADVISORY, LLC’s GSK GSK Stock Holding History

MW ADVISORY, LLC’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$216K	Buy	+4,124	New	+$218K	0.09%	134

Other funds holding GSK

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EIC

Equity Investment Corp Atlanta, Georgia $5.24B AUM 11.32% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

MHI

Miller Howard Investments Kingston, New York $3.77B AUM 23.82% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

MW ADVISORY, LLC's GSK Position: Q2 2026 in Review

MW ADVISORY, LLC opened a new position in GSK (GSK) in Q2 2026: 4,124 shares worth $216K. The stake represents 0.09% of the portfolio and ranks #134 among its holdings.

627 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

MW ADVISORY, LLC held 4,124 shares of GSK worth $216K as of Q2 2026.
GSK was a new MW ADVISORY, LLC position in Q2 2026.
GSK made up 0.09% of MW ADVISORY, LLC's portfolio in Q2 2026, its #134 holding.
627 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on MW ADVISORY, LLC's 13F filing for Q2 2026, filed 7 Aug 2026.